Skip to search.
 STI Down 0.98%

Biogen Inc. (BIIB)

-NasdaqGS
316.85 Up 7.42(2.40%) 01:46 SGT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:309.43
Open:312.52
Bid:317.00 x 500
Ask:317.33 x 200
1y Target Est:392.13
Beta:0.5
Next Earnings Date:N/A
Day's Range:308.68 - 317.72
52wk Range:290.85 - 480.18
Volume:1,927,320
Avg Vol (3m):1,939,190
Market Cap:74.51B
P/E (ttm):21.46
EPS (ttm):14.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 2.40%74.51B
PFEUp 2.52%216.78B

Key Statistics

Forward P/E (1 yr):17.87
P/S (ttm):7.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :15.95
Quarterly EPS Est (Sep-15) :3.95
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback